Avail is dedicated to furthering medical cannabis research and that is why we are launching a Nationwide Quality of Life study.
Where any patient registering through Avail between September 2021 and September 2022, will automatically be entered into the study which will be conducted through a set of questionnaires completed by patients electronically through an application which Avail has developed. This information will ultimately Provide further insight into the potential benefits of medical cannabis across a fast range of Medical ailments of which patients are already using it for.
